HK1088947A1 - Use of nicotinamide n-methyltransferase as a marker for colorectal cancer - Google Patents

Use of nicotinamide n-methyltransferase as a marker for colorectal cancer

Info

Publication number
HK1088947A1
HK1088947A1 HK06109234.1A HK06109234A HK1088947A1 HK 1088947 A1 HK1088947 A1 HK 1088947A1 HK 06109234 A HK06109234 A HK 06109234A HK 1088947 A1 HK1088947 A1 HK 1088947A1
Authority
HK
Hong Kong
Prior art keywords
colorectal cancer
methyltransferase
nicotinamide
marker
diagnosis
Prior art date
Application number
HK06109234.1A
Other languages
English (en)
Inventor
Peter Berndt
Marie-Luise Hagmann
Hanno Langen
Stefan Palme
Markus Roessler
Wolfgang Rollinger
Michael Tacke
Werner Zolg
Johann Karl
Theresa Kott
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1088947A1 publication Critical patent/HK1088947A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK06109234.1A 2002-12-20 2006-08-21 Use of nicotinamide n-methyltransferase as a marker for colorectal cancer HK1088947A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02028715 2002-12-20
PCT/EP2003/014583 WO2004057336A2 (fr) 2002-12-20 2003-12-19 Utilisation de la nicotinamide n-methyltransferase comme marqueur du cancer colorectal

Publications (1)

Publication Number Publication Date
HK1088947A1 true HK1088947A1 (en) 2006-11-17

Family

ID=32668733

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06109234.1A HK1088947A1 (en) 2002-12-20 2006-08-21 Use of nicotinamide n-methyltransferase as a marker for colorectal cancer

Country Status (14)

Country Link
US (1) US7205118B2 (fr)
EP (1) EP1579220B1 (fr)
JP (1) JP4248496B2 (fr)
KR (1) KR100711046B1 (fr)
CN (1) CN100437115C (fr)
AT (1) ATE370414T1 (fr)
AU (1) AU2003296684A1 (fr)
BR (1) BR0317394A (fr)
CA (1) CA2510377C (fr)
DE (1) DE60315715T2 (fr)
ES (1) ES2291750T3 (fr)
HK (1) HK1088947A1 (fr)
MX (1) MXPA05006382A (fr)
WO (1) WO2004057336A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60315715T2 (de) 2002-12-20 2008-06-05 Roche Diagnostics Gmbh Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
WO2005124353A1 (fr) * 2004-06-18 2005-12-29 Roch Diagnostics Gmbh Utilisation de pyrophosphatases inorganiques comme marqueur pour le cancer colorectal
WO2006066917A2 (fr) 2004-12-23 2006-06-29 Roche Diagnostics Gmbh Utilisation de la proteine asc comme marqueur du cancer colorectal
WO2006066916A1 (fr) * 2004-12-23 2006-06-29 Roche Diagnostics Gmbh Utilisation de dipeptidase microsomale comme marqueur du cancer colorectal
ATE430936T1 (de) * 2004-12-23 2009-05-15 Hoffmann La Roche Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
BRPI0520483A2 (pt) * 2005-08-19 2009-11-10 Indivumed Gmbh método para detectar adenoma colorretal e/ou carcinoma colorretal, método para discriminar entre adenoma colorretal e carcinoma colorretal ou estados adicionais de tumor, método para monitorar desenvolvimento e/ou curso e/ou tratamento de adenoma colorretal e/ou carcinoma colorretal e/ou a discriminação entre diferentes estágios de tumor, uso de fragmento de endoplasmina, sistema de teste, arranjo, método para determinar se um composto é eficaz no tratamento de adenoma colorretal e/ou carcinoma colorretal e/ou estágios especìficos de tumor
EP1966609A1 (fr) * 2005-12-22 2008-09-10 Roche Diagnostics GmbH Utilisation d'une combinaison de marqueurs comprenant l'ostéopontine et l'antigène carcinoembryonique dans l'évaluation du cancer colorectal
DE602007006671D1 (de) * 2006-08-01 2010-07-01 Roche Diagnostics Gmbh Verwendung von nnmt als marker für lungenkrebs
WO2008082646A2 (fr) * 2006-12-28 2008-07-10 The Johns Hopkins University Inhibiteurs de l'histone désacétylase, leurs procédés d'utilisation et polythérapies associées
KR100883530B1 (ko) 2007-07-30 2009-02-13 한국과학기술연구원 대장암 진단용 단백질 마커 아데노실호모시스테이나제 및이에 대한 항체를 포함하는 대장암 진단키트
KR101458483B1 (ko) * 2007-08-06 2014-11-10 제노마인(주) 신장암 진단 조성물 및 키트
CA2747942C (fr) 2008-12-22 2016-12-06 F. Hoffmann-La Roche Ag Armet en tant que marqueur du cancer
US10815517B2 (en) 2009-04-28 2020-10-27 Roche Diagnostics Operations, Inc. Use of DPPIV/seprase as a marker for cancer
CN102449484B (zh) 2009-05-29 2014-08-13 霍夫曼-拉罗奇有限公司 分离蛋白-1作为癌症标志物
EP2454596B1 (fr) 2009-07-16 2014-06-11 Roche Diagnostics GmbH Flap endonucléase-1 en tant que marqueur pour le cancer
CN102375049A (zh) * 2010-08-04 2012-03-14 索尼公司 生物信息获取方法和烟酰胺代谢物测量方法
WO2012123297A1 (fr) * 2011-03-11 2012-09-20 Roche Diagnostics Gmbh Nnmt en tant que marqueur pour une maladie pulmonaire obstructive chronique (copd)
CN106461669A (zh) * 2014-05-13 2017-02-22 瓦斯特空公司 外周血及其单核细胞中的甲硫氨酸氨肽酶过表达作为结肠直肠癌筛查、诊断和预后的标记物
CN104894073B (zh) * 2015-02-16 2018-03-27 浙江大学 杂交瘤细胞株Zj/2D8及其检测尼克酰胺‑N‑甲基化酶抗原的应用
CN110308281B (zh) * 2019-06-06 2022-08-23 北京蛋白质组研究中心 一种泛素链固相检测方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547928A (en) 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
WO1996039419A1 (fr) 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Genes et proteines specifiques du colon
WO1998020143A1 (fr) * 1996-11-05 1998-05-14 Abbott Laboratories Reactifs et procedes pour le depistage de maladies pulmonaires
WO2000012702A2 (fr) 1998-08-31 2000-03-09 Bayer Corporation Genes humains exprimes de maniere differenciee dans un cancer colorectal
US6936424B1 (en) 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
US20010055596A1 (en) 2000-03-24 2001-12-27 Meagher Madeleine Joy Compositions and methods for therapy and diagnosis of colon cancer
EP1287029A2 (fr) 2000-06-09 2003-03-05 Corixa Corporation Compositions et procedes pour la therapie et le diagnostic du cancer du colon
AU2001268259A1 (en) 2000-06-09 2001-12-24 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20020086303A1 (en) 2000-06-09 2002-07-04 Meagher Madeleine Joy Compositions and methods for the therapy and diagnosis of colon cancer
US20020110832A1 (en) 2000-08-03 2002-08-15 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
AU2001280982A1 (en) 2000-08-03 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
JP2002070501A (ja) 2000-09-04 2002-03-08 Honda Motor Co Ltd 回転流体機械
AU2002306952A1 (en) 2001-03-28 2002-10-15 Matritech, Inc. Detection and treatment of colorectal cancer
WO2002090512A2 (fr) * 2001-05-07 2002-11-14 Genaissance Pharmaceuticals, Inc. Haplotypes du gene nnmt
DE60315715T2 (de) 2002-12-20 2008-06-05 Roche Diagnostics Gmbh Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs

Also Published As

Publication number Publication date
CA2510377C (fr) 2009-11-17
JP2006510889A (ja) 2006-03-30
DE60315715D1 (de) 2007-09-27
BR0317394A (pt) 2005-11-16
WO2004057336A2 (fr) 2004-07-08
US20060003368A1 (en) 2006-01-05
EP1579220B1 (fr) 2007-08-15
DE60315715T2 (de) 2008-06-05
JP4248496B2 (ja) 2009-04-02
CN100437115C (zh) 2008-11-26
MXPA05006382A (es) 2005-10-24
CN1742204A (zh) 2006-03-01
ATE370414T1 (de) 2007-09-15
KR100711046B1 (ko) 2007-04-24
WO2004057336A3 (fr) 2005-01-20
US7205118B2 (en) 2007-04-17
CA2510377A1 (fr) 2004-07-08
KR20050114604A (ko) 2005-12-06
AU2003296684A1 (en) 2004-07-14
EP1579220A2 (fr) 2005-09-28
ES2291750T3 (es) 2008-03-01

Similar Documents

Publication Publication Date Title
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
ATE554389T1 (de) Apex als marker für lungenkrebs
WO2004055519A3 (fr) Marqueurs specifiques pour le cancer du pancreas
WO2005124356A3 (fr) Utilisation d'une proteine cbp2 en tant que marqueur pour un cancer colorectal
WO2007030949A3 (fr) Procedes de diagnostic de cancer des ovaires et necessaires a cet effet
CA2701341A1 (fr) Procede de detection du cancer colorectal a partir d'un echantillon de selles au moyen d'une combinaison de marqueurs associant la calprotectine et le complexe hemoglobine/haptoglobine
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
WO2006066917A3 (fr) Utilisation de la proteine asc comme marqueur du cancer colorectal
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
WO2010000467A8 (fr) Asc en tant que marqueur du cancer du poumon
WO2005040806A3 (fr) Utilisation de la protéine asc comme marqueur du cancer du sein
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
CA2524708A1 (fr) Utilisation de la proteine cellulaire liant l'acide retinoique (crabp ii), comme marqueur du cancer du sein
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
ATE410691T1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
ATE418737T1 (de) Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom
WO2005040807A3 (fr) Utilisation de la proteine sws2 en tant que marqueur du cancer du sein
TW200716978A (en) Method
WO2005124354A3 (fr) Utilisation de proteine comme marqueur du cancer du sein

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191219